With the analysis among 219 patents, we discovered top 17 key players by total patent application. Teva Pharmaceutical Industries Ltd., Sanofi-Aventis Deutschland GmbH, TEVA PHARMS USA are dominant in this area. They take 87.21% of the total patent filing.
Teva Pharmaceutical Industries Ltd.
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 58
New Jersey, United States
Patent: 12
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 5
Supernus Pharmaceuticals, Inc.
Golden Biotechnology Corp.
Taiwan Province, China
Patent: 4
OPKO Ireland Global Holdings Ltd.
Prilenia Therapeutics Development Ltd.
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
Prilenia Therapeutics Development Ltd.
With the analysis among related 8 patents applied in the last 5 years. We discover 7 most active companies in this area. The fast-growing Teva Pharmaceutical Industries Ltd., Jilin University, Prilenia Therapeutics Development Ltd. take 62.50% of patent filing during this period.
Teva Pharmaceutical Industries Ltd.
Jilin Sheng, China
Patent: 1
Prilenia Therapeutics Development Ltd.
OPKO Ireland Global Holdings Ltd.
Sanofi-Aventis Deutschland GmbH
New Jersey, United States
Patent: 1
Teva Pharmaceuticals International GmbH
With the analysis among related 8 patents in last 5 years, we discover 2 new entrants.
Jilin Sheng, China
Patent: 1
Teva Pharmaceuticals International GmbH
With the analysis among 5 patents, we discovered top 4 universities and scientific research institutions by total patent application. Federal University of Rio de Janeiro, Jilin University, Universidad Autónoma de Madrid are dominant in this area. They take 80.00% of the total patent filing.
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Patent: 2
Jilin Sheng, China
Patent: 1
Universidad Autónoma de Madrid